sorafenib

NEW POSSIBILITIES OF IMMUNOTHERAPY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA. LITERATURE REVIEW

от

A.Z. Isiangulova Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic named after professor M.Z. Sigal, Kazan Isiangulova Alina Z. — PhD. (Medicine), oncologist Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic named after professor M.Z. Sigal, 29 Sibirskiy Tract, Kazan, 420029, Tel.: +7 987-222-58-11, e-mail: a.isyangulova@rambler.ru, ORCHID ID: 0000-0001-8570-9921, … Читать далее

SORAFENIB IN HCC: REAL CLINICAL PRACTICE. LITERATURE REVIEW

от

I.I. Abdullin1, K.V. Menshikov1,2, A.V. Sultanbaev1,2, E.V. Popova1, O.N. Lipatov2 1Republican Clinical Oncology Dispensary, Ufa 2Bashkir State Medical University, Ufa Abdullin Ilyas I. ― oncologist of the outpatient antitumor drug therapy department of the Republican Clinical Oncology Dispensary 73/1 Oktyabrya Ave., Ufa, 450054, Russian Federation, e-mail: ilyas.abdullin.99@mail.ru, ORCID ID: 0009-0009-8470-4606 Abstract. Currently, sorafenib is a … Читать далее